Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-08-17
DOI
10.1093/rheumatology/kez407
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
- (2018) Wanlong Wu et al. ANNALS OF THE RHEUMATIC DISEASES
- Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
- (2018) W. M. T. van den Hombergh et al. CLINICAL RHEUMATOLOGY
- Long-term effects of immunosuppressive therapy on lung function in scleroderma patients
- (2018) Slavica Pavlov-Dolijanovic et al. CLINICAL RHEUMATOLOGY
- Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial
- (2018) Wieneke M. T. van den Hombergh et al. Trials
- Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
- (2018) Elizabeth R Volkmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study
- (2018) Hayakazu Sumida et al. JOURNAL OF DERMATOLOGY
- Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
- (2017) Nicole S. Goh et al. Arthritis & Rheumatology
- Update of EULAR recommendations for the treatment of systemic sclerosis
- (2016) Otylia Kowal-Bielecka et al. ANNALS OF THE RHEUMATIC DISEASES
- Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
- (2016) Giuseppina Abignano et al. RHEUMATOLOGY
- Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
- (2016) Donald P Tashkin et al. Lancet Respiratory Medicine
- Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) -- Report from OMERACT CTD-ILD Working Group
- (2015) D. Khanna et al. JOURNAL OF RHEUMATOLOGY
- 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Outperform the 1980 Criteria: Data From the Canadian Scleroderma Research Group
- (2015) Hebah Alhajeri et al. ARTHRITIS CARE & RESEARCH
- Predictive Value of Serial High-Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis
- (2015) Anna-Maria Hoffmann-Vold et al. Arthritis & Rheumatology
- Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis
- (2014) Donald P Tashkin et al. ANNALS OF THE RHEUMATIC DISEASES
- Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease
- (2014) Tiffany A. Winstone et al. CHEST
- Responders to cyclophosphamide: results of a single-centre analysis among systemic sclerosis patients
- (2012) MO Becker et al. ANNALS OF THE RHEUMATIC DISEASES
- Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease
- (2012) O. A. Moore et al. RHEUMATOLOGY
- Immunosuppression for interstitial lung disease in systemic sclerosis – novel insights and opportunities for translational research
- (2012) Marie Hudson et al. Journal of Cell Communication and Signaling
- Eficacia de la ciclofosfamida endovenosa en el tratamiento de la enfermedad pulmonar intersticial asociada a la esclerosis sistémica
- (2011) Gerard Espinosa et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group
- (2011) Dinesh Khanna et al. ARTHRITIS AND RHEUMATISM
- Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis
- (2011) Russell Steele et al. ARTHRITIS CARE & RESEARCH
- Interstitial Lung Disease in Systemic Sclerosis
- (2008) Nicole S. L. Goh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started